Ark wins contract to make gene therapy, Encap starts hot melt extrusion project, plus updates from Reciharm, Symbiosis and Applikon …

Merck has gained access to AiCuris’ portfolio of investigational medicines targeting human cytomegalovirus (HCMV) via a global licensing agreement. It …
A round-up of news in the contract research sector, including new contracts for Medpace, Particle Sciences and PRC Clinical, another …

The MSI Consultancy firm has made changes to its organisational structure with Michael Craig and Dan Heapy being promoted to …

Novartis’ multiple sclerosis (MS) drug Gilenya has demonstrated what the manufacturer calls ‘significant’ benefits for patients if used early. Results …

Johnson & Johnson continues to restructure its manufacturing network, expanding production at plants in Puerto Rico whilst setting up a …
BASF says it is planning to open a new production line in India next year that will make catalysts used …

Roche and Eli Lilly are providing drugs free of charge to US investigators conducting a worldwide trial of Alzheimer’s disease …

Woolley Pau Gyro has appointed Andy Jones to the role of creative director. Jones (pictured) was previously deputy creative director …

Boehringer Ingelheim will be delighted with final guidance from NICE recommending that its veteran drug Actilyse be used as early …

Healthcare communications agency Virgo HEALTH says its participation in a new apprenticeship scheme has been a success. The agency has …
Social media chatter on blogs, tweets and online forums is to be analysed to see whether such comments can help …
India’s clinical trials industry is facing a crisis because of growing concerns about unethical or illegal practices in the sector. …

The BioIndustry Association (BIA) has said it welcomes the appointment of UK MEP Glenis Willmott as the rapporteur for the …

The Publicis Healthcare Communications Group (PHCG) has appointed Adrian Sansone as managing director, Publicis Life Brands Medicus (PLBM). PLBM is …
French purification specialist Novasep has said it plans to invest €30 million in a new plant at its site in …

GlaxoSmithKline Vaccines has signed a deal with US not-for-profit biotech Aeras to develop a new vaccine which will treat tuberculosis …

Life sciences executive search and interim management specialists RSA has announced three new appointments. Dr François Martin (pictured) has been …

The government is attempting to encourage international organisations to help the UK’s efforts to find better treatments for dementia. An …
Targacept is to make 38% of its staff redundant and cease laboratory operations by the end of the year as …